课题基金 / 基金详情

I-Corps: Michelangelo

I-Corps: Michelangelo
I军团:米开朗基罗
批准号:
1854401
负责人:
Yoonjin Won
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-11-15 至 2019-09-30
关键词:

项目摘要

项目成果

Yoonjin Won的其他基金

相似基金

相关文献

中文摘要
翻译
I-Corps项目的广泛影响/商业潜力使医生、护士和其他医疗保健人员能够以更有效和更安全的方式向患者提供药物,从而大大减少医疗保健环境中发生的药物错误数量。据一项研究计算,1993年美国因这一问题造成的经济损失超过20亿美元,导致住院时间延长、收入损失和保险费增加。更重要的是,这些错误可以追溯到7 000多人的死亡。消费者群体包括任何管理药物的医疗机构,包括医疗中心、学术医院、大城市和地区医院、外科中心、紧急护理中心、牙科和兽医办公室以及养老院。这个I-Corps项目是一个医疗设备的建议,旨在减少用药错误,并与医院目前使用的小瓶兼容。它使用摄像头读取小瓶上的打印代码,以确定药物的安全性、禁忌症、有效期、制造商召回和以前的使用情况,从而在不使用针头、注射器或标签的情况下分配药物。它还将减少药物递送时间、药物不良反应、污染、假冒和浪费。我们的设备还包括一个后端数据库,该数据库跟踪标有代码的药物,以提供给患者的药物记录。数据库可以更新,以防止交付召回,过期和以前使用过的药物。该设备的基础是条形码给药(BCMA)系统,用于给患者用药和管理药房的药物库存。大多数用药错误是由于使用多种不同来源的静脉注射药物引起的,也是麻醉师引起并发症的主要原因。该设备可以提高工作效率,并通过自动提醒麻醉师禁忌药物和过敏,发送重新给药提醒和记录药物管理,提供多重安全网。该奖项反映了美国国家科学基金会的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
The broader impact/commercial potential of this I-Corps project allows physicians, nurses, and other healthcare personnel to give medication to their patients in a more efficient and safe manner by significantly reducing the number of medication errors made in health care settings. One study calculated the economic costs of this problem in the United States to be over $2 billion in 1993, leading to longer hospitalizations, loss of income, and higher insurance premiums. Of greater importance, these errors can be traced to over 7,000 deaths. Consumer segments include any medical institution that administers medications including medical centers, academic, major metropolitan, and regional hospitals, surgery centers, urgent care centers, dental and veterinarian offices, and nursing homes.This I-Corps project is a proposal for a medical device designed to decrease medication errors and be compatible with vials currently used in the hospital. It uses cameras to read a printed code on a vial to positively identify the medication for safety, contraindications, expiration, manufacturer recall, and previous usage to dispense medication contained inside without the use of needles, syringes, or labels. It will also decrease medication delivery times, adverse drug reactions, contamination, counterfeiting, and waste. Our device also consists of a backend database that keeps track of medications tagged with a code to provide a record of medication given to patients. The database can be updated to prevent the delivery of recalled, expired, and previously used medications. The basis of this device is a barcode medication administration (BCMA) system to give medication to patients and manage inventory of medications in pharmacies. Most medication errors occur from the use of intravenous medications from a number of different sources and are the leading cause of complications by anesthetists. This apparatus can improve workflow efficiency and provide multiple safety nets by automatically alerting the anesthetist to contraindicated medications and allergies, sending reminders for redosing medications, and documenting medication administration.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONFERENCE: The 2nd micro Flow and Interfacial Phenomena (μFIP)
  • 批准号:
    2230749
  • 项目类别:
    Standard Grant
  • 资助金额:
    $0.45万
  • 财政年份:
    2022
  • 负责人:
    Yoonjin Won
  • 依托单位:
Collaborative Research: Interactions of Interlayered Nanoporous Graphene with Surrounding Water Molecules
  • 批准号:
    2035584
  • 项目类别:
    Standard Grant
  • 资助金额:
    $54.0万
  • 财政年份:
    2021
  • 负责人:
    Yoonjin Won
  • 依托单位:
Learning pool boiling physics with scientific machine learning
  • 批准号:
    2045322
  • 项目类别:
    Standard Grant
  • 资助金额:
    $40.0万
  • 财政年份:
    2021
  • 负责人:
    Yoonjin Won
  • 依托单位:
CAREER: Fundamental Investigation of Thin-Film Evaporation Using Crystalline Porous Inverse Opals
  • 批准号:
    1752147
  • 项目类别:
    Standard Grant
  • 资助金额:
    $50.0万
  • 财政年份:
    2018
  • 负责人:
    Yoonjin Won
  • 依托单位:
海外基金